Table 2:

Clinical outcomes before and after matching

Before MatchingPAfter MatchingP
ST 6 (n = 256)ST 4 (n = 372)ST 6 (n = 169)ST 4 (n = 169)
mTICI.013.532
    0–2a (No.) (%)51 (19.9%)47 (12.6%)31 (18.3%)26 (15.4%)
    2b–3 (No.) (%)205 (80.1%)325 (87.4%)138 (81.7%)143 (84.6%)
Workflow time
    Time from puncture to reperfusion (median) (IQR) (min)111.5 (80–153)97 (72–140).007108 (75–147)100 (75–156)1.000
    Time from stent deployment to reperfusion (median) (IQR) (min)61 (30–94)44 (20–75)<.00158 (30–87)45 (21–82).021
    Passes (median) (IQR)2 (1–3)2 (1–3).0012 (1–3)2 (1–3).375
        ≤3 (No.) (%)210 (82%)323 (86.8%).099106 (62.7%)119 (70.4%).154
    Rescue therapy (No.) (%)134 (52.3%)184 (49.5%).47885 (50.3%)84 (49.7%)1.000
Complications
    Vessel dissection (No.) (%)3 (1.2%)6 (1.6%).7442 (1.2%)5 (3.0%).453
    Arterial perforation (No.) (%)2 (0.8%)6 (1.6%).4822 (1.2%)2 (1.2%)1.000
    Stent failure to deploy (No.) (%)1 (0.4%)0.4081 (0.6%)01.000
    Isolated SAH (No.) (%)4 (1.6%)9 (2.4%).4593 (1.8%)1 (0.6%).625
    Symptomatic ICH (No.) (%)41 (16%)60 (16.1%).97022 (13%)27 (16%).511
    Asymptomatic ICH (No.) (%)92 (35.9%)118 (31.7%).27156 (33.1%)67 (39.6%).248
mRS 90 days.003.087
    0–2 (No.) (%)89 (34.8%)173 (46.5%)64 (37.9%)79 (46.7%)
    3–6 (No.) (%)167 (65.2%)199 (53.5%)105 (62.1%)90 (53.3%)
    In-hospital mortality (No.) (%)74 (28.9%)78 (21%).02238 (22.5%)39 (23.1%)1.000
  • Note:—ICH indicates intracerebral hemorrhage.